Novartis has committed up to $3 billion—two-thirds of that upfront—toward acquiring Pikavation Therapeutics, a subsidiary of Synnovation Therapeutics that specializes in developing PI3Kα inhibitor ...

The life science industry employs 18,000 people in central Ohio and 64,000 across the state, according to the Ohio Life Sciences Association.

To test whether AT2‑derived lipids are required for metastasis, the researchers selectively deleted Fasn in AT2 cells.

The researchers say that, to their knowledge, this is the first demonstration of programmable, site-specific integration of a large DNA payload into T cells in vivo.

The model has the potential to transform the ability to study telomere biology, learn more about human aging, and ultimately help people preserve better health as they age.

Findings from preclinical studies could point to therapeutic strategies for Huntington’s disease, as well as other neurodegenerative disorders and potentially cancer.

Liège-based Bio‑Sourcing and Roanoke-based The Tiny Cargo Company inked a strategic collaboration to co‑develop orally delivered monoclonal antibody (mAb)-based therapies formulated using goat ...

Researchers say discovery could establish the basis for a novel, tandem biomarker-peptide therapeutic approach to schizophrenia.

A new strategy strengthens the bond between the T cell and a target tumor cell, improving the cytotoxic function of the T cell.

Roche’s AI factories, protein design reasoning model, and healthcare robotics are among GTC announcements for biology.

Cayman advanced the protocol from a 1-L setup to a 100-L pilot run, operating the reaction and analysis independently.

Astellas Pharma has ended a six-year-old collaboration with CytomX Therapeutics designed to both expand the pharma giant’s pipeline of next-gen immuno-oncology treatments and generate up to $1.68 ...